ALT STOCK: Robbins LLP Reminds ALT Stockholders of the Opportunity to Lead the Class Action Lawsuit Against Altimmune, Inc. - Candlesense
ALT Lawsuits

ALT STOCK: Robbins LLP Reminds ALT Stockholders of the Opportunity to Lead the Class Action Lawsuit Against Altimmune, Inc.

SAN DIEGO, Aug. 20, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Altimmune, Inc. (NASDAQ: ALT) securities between August 10, 2023 and June 25, 2025. Altimmune is a clinical stage...

Related Questions

What potential downside could the class action lawsuit have on ALT's share price in the short term? When is the expected timeline for the lawsuit resolution and any possible settlement? How might the lawsuit affect ALT's ability to secure future financing or partnerships?
Find similar articles on Candlesense prnewswire